CF Bankshares Q2 earnings climb 18%, but credit quality sharply deteriorates
CFBK sits 64% above its 52-week low of $22.1 on light trading volume (0.2× avg).
Summary
CF Bankshares reported Q2 net income of $5.9 million ($0.90 diluted EPS), an 18% gain over Q1, but nonperforming loans surged to $20.8 million and criticized loans more than doubled. CEO Timothy O'Dell adopted a 10b5-1 trading plan to sell up to 60,000 shares.
Key Events · Earnings and Guidance · CFBK
-
Q2 Earnings Beat
Net income reached $5.9 million ($0.90 diluted EPS), an 18% increase from Q1 2026, supported by a 6% rise in net interest income and a net interest margin that widened to 2.93%.
-
Credit Quality Deterioration
Nonperforming loans climbed to $20.8 million (1.15% of total loans) from $15.3 million at year-end 2025. Criticized and classified loans surged 123.1% to $64.2 million, driven by three downgraded relationships.
-
CEO Adopts 10b5-1 Trading Plan
On May 13, 2026, CEO Timothy O'Dell adopted a Rule 10b5-1 trading plan to sell up to 60,000 shares (limited to 15,000 per quarter) for estate and financial planning purposes.
-
Capital Remains Strong
CFBank remains well-capitalized with a Tier 1 leverage ratio of 11.64%, well above regulatory minimums. Total stockholders' equity increased 5.4% to $194.3 million.
Analysis · CFBK · Finance
CF Bankshares delivered a strong second quarter, with net income rising 18% sequentially to $5.9 million, fueled by a wider net interest margin. Yet the upbeat earnings are overshadowed by a significant worsening in credit quality: nonperforming loans jumped to $20.8 million, and criticized/classified loans more than doubled to $64.2 million. Adding to the cautionary signals, the CEO adopted a 10b5-1 plan to sell up to 60,000 shares. The rapid deterioration in loan quality could pressure future provisions and capital, tempering the earnings beat.
At the time of this filing, CFBK was trading at $36.19 on NASDAQ in the Finance sector, with a market capitalization of approximately $235.2M. The 52-week trading range was $22.10 to $36.95. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.